| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4271573 | The Journal of Sexual Medicine | 2010 | 8 Pages |
Abstract
In this prospective multicenter study, TU was effective, safe, and tolerable until 24 weeks in Korean TDS patients. Further well-controlled, long-term study should follow. Moon DG, Park MG, Lee SW, Park K, Park JK, Kim SW, Park NC, Ahn TY, Paick JS, Seo JT, Yang DY, Lee JY, and Kim JJ. The efficacy and safety of testosterone undecanoate (Nebido®) in testosterone deficiency syndrome in Korean: A multicenter prospective study.
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Du Geon MD, PhD, Min Gu MD, PhD, Sung Won MD, PhD, Kwangsung MD, PhD, Jong Kwan MD, PhD, Sae Woong MD, PhD, Nam Cheol MD, PhD, Tai Young MD, PhD, Jae Seung MD, PhD, Ju Tae MD, PhD, Dae Yul MD, PhD, June Young PhD, Je Jong MD, PhD,